Alzheimer’s disease is commonly treated with a centrally acting:Group of answer choicesdopamine receptor antagonist.acetylcholinesterase inhibitor.choline acetyltransferase inhibitor.acetylcholine receptor antagonist.

In general, symptomatic treatment for Alzheimer's diseaseQuestion 9Select one:a.are most helpful in the later stages of Alzheimer's diseaseb.have a low likelihood of adverse reactionsc.have clinically marginal benefitsd.have homogeneous and predictable responses

Select the correct statement(s).Group of answer choicesDementia is common in the elderly and is considered part of normal ageing.Prominent brain areas affected the most by Alzheimer’s disease are the prefrontal cortex, amygdala, and hippocampus.Alzheimer’s disease is associated with intracellular accumulation of amyloid beta plaques and extracellular deposition of abnormal tau proteins.Alzheimer’s disease is associated with a significant reduction of cholinergic neurons in the brain, which explains why administration of acetylcholinesterase inhibitors appears to be advantageous in the management of this condition.

Cholinesterase inhibitors such as Donepezil target which symptom of Alzheimer Disease?Question 6Select one:a.Cognitive impairmentb.Physical deconditioningc.Sleep impairmentd.Global functioning

What do current medications and approaches to Alzheimer's disease focus on?Slowing down symptoms of the diseaseCuring the diseaseIncreasing short-term memoryIncreasing long-term memory

Improve this abstract ensuring it sounds clear and capture the reader : Amidst the burgeoning global challenge of dementia, Alzheimer's Disease (AD) stands as a formidable adversary, progressively encroaching upon cognition, daily functioning, and behavior among the elderly. With the specter of an aging population looming large, the imperative for effective interventions becomes ever more pressing. This comprehensive review delves into the intricate realm of non-pharmacological therapies (NPTs), dissecting their potential to offer respite amidst the tumult of AD. From cognitive interventions to brain stimulation and psychological care, each modality presents a unique avenue for exploration. As we traverse this terrain of therapeutic possibilities, we confront not only the complexities of AD management but also the tantalizing prospect of advancing research. Through this scholarly exploration, we seek not merely to illuminate the current landscape but to chart a course towards enhanced understanding and efficacy in the treatment of AD.